Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Core Insights - Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing next-generation therapies for severe autoimmune diseases [3] Group 1: Company Participation - Dianthus Therapeutics will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York City [1] - CEO Marino Garcia will engage in an analyst-led fireside chat on February 12, 2026, at 10:00 am EST and will conduct one-on-one meetings with investors [1] Group 2: Company Overview - The company is based in New York City and Waltham, Massachusetts, and is led by an experienced team of biotech and pharmaceutical executives [3] - Dianthus aims to deliver transformative medicines for individuals suffering from severe autoimmune and inflammatory diseases [3]